Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer

Liver cancer is a leading cause of cancer deaths worldwide. The combination therapy of cytotoxic and chemosensitizing agents loaded in nanoparticles has been highlighted as an effective treatment for different cancers. However, such studies in liver cancer remain very limited. In our study, we aim t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiaojing, Chen, Qi, Liu, Wei, Li, Yusang, Tang, Hebin, Liu, Xuhan, Yang, Xiangliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284012/
https://www.ncbi.nlm.nih.gov/pubmed/25565818
http://dx.doi.org/10.2147/IJN.S73322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284012/
https://www.ncbi.nlm.nih.gov/pubmed/25565818
http://dx.doi.org/10.2147/IJN.S73322

Ejemplares similares